India pharma industry imports most of the KSMs, intermediates and reasonable quantities of APIs. Majority of these are from one single source – China, which has been affected.
As India Pharma Inc strives to enter new, previously unexplored markets and battles unprecedented challenges, ‘Think Global, Act Local’ approach might be one of the strategies to derive a competitive advantage